Anastazia A. Kei
Ioannina, ESYE21, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Diagnostic lipid changes in patients with visceral leishmaniasis.
Journal: Hospital practice (1995)
Published: June 01, 2018
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
Journal: Diseases (Basel, Switzerland)
Published: September 14, 2017
Uric acid and cardiovascular risk: What genes can say.
Journal: International journal of clinical practice
Published: September 12, 2017
Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: August 23, 2017
Vorapaxar in secondary prevention: where we stand.
Journal: Current medical research and opinion
Published: June 13, 2017
The current role of thiazolidinediones in diabetes management.
Journal: Archives of toxicology
Published: April 24, 2016
The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia.
Journal: Expert opinion on drug safety
Published: February 23, 2016
Hypertriglyceridemia, remnant cholesterol and cardiovascular risk: what genes can say.
Journal: International journal of clinical practice
Published: January 29, 2016
Statin use in prediabetic patients: rationale and results to date.
Journal: Therapeutic advances in chronic disease
Published: September 04, 2015
No effect of switching to high-dose rosuvastatin, add-on nicotinic acid, or add-on fenofibrate on serum vitamin D levels in patients with mixed dyslipidemia.
Journal: Hippokratia
Published: April 01, 2015
Emerging drugs for hyperlipidaemia: an update.
Journal: Expert opinion on emerging drugs
Published: October 31, 2014
Dysbetalipoproteinemia: Two cases report and a diagnostic algorithm.
Journal: World journal of clinical cases
Published: October 14, 2014
Last Updated: 09/26/2026